FXa Anticoagulant Bioactive Proteins Derived from Scorpion Venom
Poster Jul 31, 2019
Meng Li, Yuko P. Y. Lam, Peng Chen, Remy Gavard, Cookson K. C. Chiu, Christopher A. Wootton, Tomos E. Morgan, Qiong Wu, Mark P. Barrow, Hongzheng Fu, Peter B. O’Connor
Scorpion venom is a highly complex mixture of proteins which have shown a diverse variety of pharmaceutical properties for the treatment of many conditions, such as cardiovascular problems, drug dependence, chronic pain, diabetes, and even tumors.
Download this poster:
- For insights on the various analytical tools and methods used to narrow down and identify potential therapeutic targets
- To learn how these tools can be used to identify leads from other natural products
Biologics-based medicines is a rapidly growing field and a promising solution to address many unmet medical needs. Biopharmaceutical developers are actively looking for more efficient and robust production platforms to reduce timelines and overall development costs. Gibco™ Expi™ Expression Systems are complete platforms that can speed up biologics development.READ MORE